Regenerative Psychiatry, Autonomic Recovery - Reno, NV

Vagal Nerve Stimulation: Waking Up Your Body's Own Calming Switch

Gently activating the vagus nerve at the ear, no needles and no surgery, to train your nervous system to downshift out of fight-or-flight.

Your body already has a built-in braking system for stress: the vagus nerve, running from your brainstem down through your neck and into your chest and gut. When it's working well, it slows your heart rate, calms inflammation, and helps your nervous system downshift. Chronic stress and trauma can leave that system underused and out of tone, so the "calm down" signal doesn't fire the way it should.

This is a supportive layer, not a stand-alone treatment. We use it alongside other therapies as part of a broader, individualized plan, tracked through your own heart rate variability data, not a generic one-size-fits-all setting.

"VNS doesn't work by sedating you or forcing calm from the outside. It works by directly activating a reflex your body already has, and helping it fire more reliably again."

Clinical Note: VNS is one supportive layer within a broader, individualized plan, not a stand-alone treatment for anxiety, depression, or trauma and not a substitute for therapy, medication, or the rest of your care. It is not appropriate for patients with certain cardiac conduction abnormalities or implanted cardiac devices, which we screen for during your evaluation. If you are in crisis, call or text 988, call 911, or go to the nearest emergency department.

What It Is

Illustration of a translucent human brain with glowing neural connections inside a rounded square frame on a light background.

External, at the Ear, Two Pathways at Once

Transcutaneous auricular vagal nerve stimulation: a small electrode at a specific point on the outer ear (the cymba conchae) where a branch of the vagus nerve sits close to the surface. A gentle pulse activates it, no needles, no surgery. The signal splits into two pathways, one that calms an overactive amygdala and supports BDNF, and one that runs through the body's own anti-inflammatory reflex. It is the only non-drug tool we use that activates both at once.

How We Use it

Icon of a clipboard with four check marks and a bar chart next to a transparent graduated cylinder filled halfway with blue liquid, set against a shiny, metallic background.

Layered In, Titrated to Your HRV

In-office, VNS runs concurrently with treatment you are already receiving, most often IV nutrient sessions and photobiomodulation, so it adds no separate appointment time (a typical session runs 30 minutes). We often prescribe daily at-home use once you are past the in-office phase. Your own baseline heart rate variability guides how we titrate intensity and frequency, not a fixed setting applied to everyone.

Who It's For

Icon of an intravenous (IV) bag with a diagonal prohibition symbol overlay, indicating no IV or infusion.

A Nervous System That Won't Downshift

Patients whose nervous system stays stuck in overdrive with no active threat: low heart rate variability, chronic anxiety, disrupted sleep, or an inflammatory burden sustaining mood or cognitive symptoms. It shows up specifically for autonomic dysregulation and chronic stress load, and for cognitive-optimization patients whose nervous system never fully downshifts between demands.

The Mechanism, In Detail

VNS activates a reflex your body already has, through several distinct pathways:

1

The Calming & Growth-Factor Pathway

Activating the vagus nerve at the ear sends a signal through your brainstem to the locus coeruleus, which releases norepinephrine in a way that helps activate your prefrontal cortex (higher-reasoning center) while calming an overactive amygdala. The same pathway supports BDNF, the growth factor your brain needs to build and strengthen healthy new connections.

2

The Anti-Inflammatory Reflex

A second pathway runs from the same brainstem relay down through the dorsal motor nucleus and spleen, dampening the release of inflammatory chemicals (TNF-alpha, IL-1beta, IL-6). This is a well-documented reflex, with trial evidence in rheumatoid arthritis, inflammatory bowel disease, and postoperative inflammation. Its specific role in mood and cognition is a biologically grounded extension, not yet directly proven in dedicated psychiatric trials.

3

Heart Rate Variability as a Direct Outcome

HRV, specifically a measure called RMSSD, is a direct readout of how well your vagus nerve is doing its job. Improving it isn't a side effect of VNS; it is one of the primary things VNS is designed to do, and the metric we use to track whether treatment is working for you specifically.

Why We Measure Your Baseline First

VNS is not applied the same way to everyone, and it is not automatically a fit for every patient. Published research shows that people with an already low baseline heart rate variability tend to respond well, while people who already have a high, healthy baseline can, in some studies, respond in the opposite direction, with heart rate and an inflammatory marker rising rather than falling. That is exactly why we measure your baseline heart rate variability before starting, and use it to guide whether and how VNS fits your plan, rather than offering it as a default add-on for everyone.

How A VNS Course Works

Screen & Measure
Baseline HRV

Step 01 - Screen & Measure Baseline HRV

We screen for contraindications (certain cardiac conduction abnormalities or implanted cardiac devices) and measure your baseline heart rate variability, which helps determine whether and how VNS fits your plan at all.

The Evidence

Ear-based vagal nerve stimulation has a real and growing research base, and we describe each study by what it actually studied:

  • Autonomic mechanism

    A controlled study in 48 healthy volunteers found this ear-based technique significantly increased HRV and reduced sympathetic nerve activity, measured directly (Clancy 2014).

  • Depression

    A 107-patient randomized trial compared this technique head-to-head against citalopram, a standard prescription antidepressant, for major depression: both improved symptoms similarly overall, but taVNS produced a significantly higher remission rate at weeks four and six, meaningfully faster relief than the medication arm (Li 2022). An earlier nonrandomized controlled pilot showed symptom improvement (Rong 2016); a randomized crossover trial found the meaningful effect after splitting participants by their own baseline HRV (Schiweck 2025); and a brain-imaging study in women with active depression, using a related auricular technique distinct from the specific device we use, found stimulation produced activation changes in mood- and stress-regulating regions that tracked with real reductions in depressive and anxiety symptoms after a stress challenge (Garcia 2021).

  • Anxiety

    A double-blind, sham-controlled randomized trial in university students with elevated anxiety found anxiety scores dropped substantially with active treatment, with the improvement still holding two weeks after the intervention ended (Ferreira 2024). A separate randomized, double-blind trial found improved anxiety symptoms in patients with Parkinson's disease who also had anxiety, a specific medical population rather than a general anxiety sample (Zhang 2024).

  • Depression and anxiety together

    A feasibility trial in ten inpatient psychiatric admissions with combined depression and anxiety found statistically significant improvement from baseline on all four validated symptom scales used (two for depression, two for anxiety). It is open-label and small, worth naming plainly, but a real signal in a more acutely unwell population than most published research on this technique (Austelle 2025).

  • PTSD

    A small feasibility study in trauma-exposed World Trade Center responders found a numerically larger PTSD improvement than sham (40 percent versus 28.5 percent reaching a meaningful CAPS-5 improvement), but the difference was not statistically significant, an early, promising, but unproven signal (Debnath 2026).

Honest calibration:

This is real, peer-reviewed human research across depression, anxiety, sleep, and the autonomic mechanism itself, plus an early PTSD signal that has not yet reached statistical significance. We use VNS as one supportive layer within a broader, individualized plan tracked through your own HRV, not a stand-alone cure.

Where VNS Fits Alongside Our Other Recovery Tools

VNS is one of three complementary, non-pharmacological technologies we use in-office, each targeting a genuinely different mechanism. We don't stack them arbitrarily; each is matched to what your presentation and lab/HRV picture actually call for.

Vagal Nerve Stimulation

Direct autonomic and anti-inflammatory support through the vagus nerve.

PEMF

Sleep architecture and parasympathetic/autonomic recovery (see our PEMF page).

Photobiomodulation (Neuro Gamma)

Near-infrared light supporting brain-cell energy metabolism and neuroplasticity (see our Neuro Gamma page).

Within a plan, VNS is run concurrently with IV nutrient sessions and photobiomodulation so it adds no appointment time, and paired with neural therapy and other autonomic-focused work as a second, independent way of supporting the same parasympathetic shift.

What This Is Not

Not a stand-alone treatment for anxiety, depression, or trauma.
Not a substitute for therapy, medication, or the rest of your treatment plan.
Not sedating, and not something that produces an immediate, dramatic effect in a single session.
Not appropriate for patients with certain cardiac conduction abnormalities or implanted cardiac devices; this is screened during your evaluation.

F.A.Q.

Is this the same as the surgically implanted vagal nerve stimulator used for epilepsy?

No. That is an invasive device implanted around the vagus nerve in the neck, requiring surgery. What we use is entirely external, placed at a point on your outer ear, with no surgery and no implant.

Will I feel anything during a session?

Most patients feel a mild tingling sensation at the ear, adjusted to a comfortable level. It is not painful.

How long is a session?

Typically 30 minutes, often run alongside another treatment you are already having so it doesn't add separate time.

Can I use this at home?

Yes. Many patients are prescribed a take-home device for daily use once their in-office titration phase is complete.

How soon will I notice a difference?

Heart rate variability changes are often visible within a couple of weeks of consistent use. Symptom-level change, especially for inflammation-related presentations, may take longer and is tracked throughout your care.

Which of your programs use VNS?

It is referenced across our anxiety, autonomic dysregulation, and cognitive optimization work, always matched to what your specific presentation and HRV baseline indicate, not applied identically to every patient.

Josh Swigart Portrait

Josh Swigart, APRN, PMHNP-BC. Measurement-informed, biology-first psychiatry.

Josh Swigart, APRN, PMHNP-BC. Regenerative Psychiatry, Neuroplasticity, Cognitive Performance Medicine. KRI Fellow, A4M ABAAHP Fellow-in-Training, Triple Certified Peptide Therapy, Advanced IVNT Certified, Double Certified Neural Therapy, Koniver Method Clinician.

Josh Swigart Portrait

Retrain your body's own calming reflex

If a nervous system stuck in overdrive, low heart rate variability, or an underlying inflammatory load is part of your picture, VNS may be one supportive layer worth evaluating, once we have measured your baseline. Whether and how it fits comes out of your intake and your own HRV data, not a default applied to everyone.

Serene mountain landscape surrounding a calm lake, with soft lavender and warm tones fading into a bright white center.

References

[1] Clancy JA, Mary DA, Witte KK, Greenwood JP, Deuchars SA, Deuchars J (2014). Non-invasive vagus nerve stimulation increases HRV and reducessympathetic activity. Brain Stimulation, 7(6):871-877. PMID 25164906. 48 healthy volunteers; significant increase in HRV and reduced sympathetic nerve activityby microneurography.

[2] Rong P, et al. (2016). Transcutaneous auricular VNS in major depressive disorder, nonrandomized controlled pilot. Journal of Affective Disorders, 195:172-179.PMID 26896810. Real depression-symptom outcome data; nonrandomized, so early pilot-level evidence, not a definitive trial.

[3] Li S, Rong P, et al. (2022). taVNS versus citalopram in major depressive disorder, randomized trial. Neuromodulation, 25(3):450-460. PMID 35088753. 107patients; comparable overall improvement to the antidepressant citalopram, with a significantly higher remission rate at weeks four and six, meaningfully fasterrelief than the medication arm.

[4] Garcia RG, et al. (2021). Auricular vagal stimulation and brain response in depression, imaging study. Journal of Psychiatric Research, 142:188-197. PMID34365067. Women with active major depression; a related auricular technique (distinct from the device used here) produced activation changes in mood- andstress-regulating brain regions that tracked with reductions in depressive and anxiety symptoms after a stress challenge.

[5] Schiweck C, et al. (2025). taVNS during acute stress, randomized crossover trial. Translational Psychiatry, 15(1):521. PMID 41353184. 110 participants; nooverall group difference, but in lower-baseline-HRV participants taVNS restored a blunted stress response and lowered TNF-alpha, while higher-baseline-HRVparticipants responded in the opposite direction.

[6] Zhang H, et al. (2024). taVNS for anxiety in Parkinson's disease, RCT. Journal of Affective Disorders, 361:556-563. PMID 38925314. Randomized, doubleblind; improved anxiety and task-related brain activity, in a specific medical population.

[7] Ferreira LMA, et al. (2024). taVNS for elevated anxiety, double-blind sham-controlled RCT. Frontiers in Integrative Neuroscience, 18:1422312. PMID39051059. 42 university students with elevated anxiety; substantial reduction in anxiety scores that still held two weeks after the intervention ended.

[8] Austelle CW, et al. (2025). taVNS in inpatients with depression and anxiety, feasibility trial. Neuromodulation, 28(4):672-681. PMID 40117415. Ten inpatientpsychiatric admissions; statistically significant improvement from baseline on all four validated scales (two for depression, two for anxiety). Open-label and small,but a real signal in a more acutely unwell population than most published research on this technique.

[9] Debnath S, et al. (2026). taVNS in trauma-exposed responders with PTSD, feasibility study. International Journal of Environmental Research and PublicHealth, 23(3):401. PMID 41899778. n=32; numerically larger PTSD improvement than sham (40 percent versus 28.5 percent reaching a meaningful CAPS-5change), not statistically significant; an early, promising, but unproven signal.

This page is for general education and is not a diagnosis, a substitute for individualized medical advice, or a promise of any specific result. VNS is used as one supportive layer within an individualized plan, after screening and baseline measurement, and is titrated and tracked through your own heart rate variability over time. If you are in crisis, call or text 988, call 911, or go to the nearest emergency department. Peak Body and Mind - 530 Hammill Ln, Reno, NV 89511 - (775) 376-1124 - peak@peakbodymind.com

PRIVATE BRIEF - your information stays confidential.